Skip to content
Search

Latest Stories

Action on UK's pandemic disparities 'needed now more than ever': Experts

By S Neeraj Krishna

HEALTH and social leaders in the UK have cautioned that action to tackle disproportionate impact of the pandemic is “needed now more than ever”.


Concerns were raised over the weekend as reports said one-third of Covid-19 patients in intensive care were from black, Asian and minority ethnic (BAME) backgrounds.

The British Medical Association said government failure to implement remedial measures could lead to more disproportionate deaths as seen earlier in the UK.

That would imply the UK was failing to protect “our vulnerable communities”, said Dr Chaand Nagpaul, the BMA council chair, who had in April urged the government to order a probe into why BAME people were disproportionately affected by the coronavirus crisis.

Several reports -- including one from Public Health England – had concluded that people from some ethnic groups were significantly higher risks. However, experts noted, little action had on this disparity.

“We are continuing to see BAME people suffering disproportionately in terms of intensive care admissions, so not acting means that we’re not protecting our vulnerable communities,” Nagpaul told the Guardian.

“Action was needed back in July and it’s certainly needed now more than ever.

“As the infection rate rises, there’s no reason to believe that the BAME population will not suffer again because no action has been taken to protect them. They are still at higher risk of serious ill health and dying.”

Following widespread criticism of the PHE analysis in June for its failure to detail an action plan, Health Secretary Matt Hancock assured that the government would outline “what further could be done”.

A subsequent PHE report put forth many measures such as engaging BAME groups in research to help understand the social, economic and cultural tangents of the pandemic.

It also called for enhancing NHS experiences for BAME patients, and boosting diverse representation at various staff levels.

Other key plans included implementing “culturally competent” health campaigns, and long-term reforms to eliminate racial inequalities.

Nagpaul observed that most recommendations had just remained on paper.

“I am deeply concerned that three months since the publication of the PHE review, we have heard nothing from the government around any specific action or implementation of any of the recommendations,” he said.

“We must remind ourselves that the purpose of the review was to protect a sector of our population who have been disproportionately harmed.”

Dr Zubaida Haque, member of the Independent Scientific Advisory Group for Emergencies, said: “A good point to start is to ask the government: ‘What exactly have you done?’ Because we haven’t seen anything that they’ve done. It does feel like the ball’s been kicked into the long grass with the recommendations because we’ve never seen nor heard anything and we’re on the verge of the second wave.

“Have they set up necessary … accommodation support [for people self-isolating] and have they ensured that the public health messages around social distancing and help for self-isolation is reaching black and ethnic minority people on the ground, including those who may not be fluent [in English]?”

Operation Black Vote director Simon Woolley, who had mooted a national Covid-19 race equality strategy, warned that the second coronavirus wave “will take away those that are most vulnerable”.

“Without a clear health plan…  we could be hit again,” he added.

A government spokesperson said the equalities minister was “taking forward vital work to tackle disparities and protect our most vulnerable communities”.

On Sunday (20), the government announced a support package to provide a £500 payment to low-paid workers who lose income due to mandatory self-isolation, starting from from September 28.

“This work will continue throughout 2020 and 2021 and the first of the quarterly updates will be provided to the health secretary and the prime minister in the coming weeks,” the spokesperson added. “This will show progress made against the published terms of reference and action taken to tackle Covid-19 disparities.”

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less